Retapamulin reveals high rates of clinical success in impetigo

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1577, 2007-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retapamulin: a guide to its use in impetigo and other uncomplicated superficial skin infections

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 10, 2008-10 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Retapamulin: A Review of its Use in the Management of Impetigo and Other Uncomplicated Superficial Skin Infections

By Yang Lily P.H.   Keam Susan J.  

Drugs, Vol. 68, Iss. 6, 2008-01 ,pp. : 855-873

Adis International

Access to resources Recommend Favorite

High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: Results of a meta-analysis of clinical trials

By Römkens Tessa E.H.   Kampschreur Milou T.   Drenth Joost P.H.   van Oijen Martijn G.H.   de Jong Dirk J.  

Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. : 2190-2198

Blackwell Publishing

Access to resources Recommend Favorite

Retapamulin: Allergic contact dermatitis: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1285, 2010-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

High VTE rates with thalidomide, lenalidomide

By  

Reactions Weekly, Vol. 1, Iss. 1133, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite